Aims and Scope

Journal of Heart and Lung Research is a peer-reviewed, open access, international journal providing rapid publication of research from global researchers across biomedical and clinical fields. It is quarterly published by Exploration and Verfication Publishing and the publication language is English.

This journal aims to better understand basic, experimental, translational, and clinical practices of cardiovascular system and respiratory system, providing a forum for researchers and clinicians to improve the prevention, risk factors, mechanisms, diagnosis, pharmacology, surgery, transplantation, and treatment of heart and lung diseases, with emphasis on combined therapies and nursing between heart and lung, facilitating interdisciplinary collaboration among researchers, clinicians, and healthcare professionals. Papers on cardiorespiratory health, cardiac diseases, pulmonary diseases, relevant medical devices, imaging techniques, therapeutic innovations, novel opinions on mechanism and physiology of heart and lung are welcome.

The journal will consider all submissions related to heart and lung research, including, but not limited to, the following areas:

· heart research;
· lung research;
· cardiovascular system;
· respiratory system;
· cardiorespiratory health;
· cardiac diseases;
· cardiovascular diseases;
· coronary artery disease;
· heart failure;
· arrhythmias;
· congenital heart defects;
· cardiomyopathies;
· valvular heart disease;
· peripheral arterial disease;
· pulmonary diseases;
· asthma;
· chronic obstructive pulmonary disease (COPD);
· interstitial lung disease;
· pulmonary hypertension;
· cystic fibrosis;
· sleep-disordered breathing;
· respiratory infections;
· diagnosis and monitoring of heart and lung diseases;
· echocardiography;
· prevention and risk factors of heart and lung diseases;
· pathogenesis of heart and lung diseases;
· treatment and prognosis of heart and lung diseases;
· pharmacological treatments of heart and lung diseases;
· surgical interventions of heart and lung diseases;
· mechanical support devices and regenerative medicine approaches of heart and lung diseases;
· epidemiology and public health relevant to heart and lung;
· healthcare delivery for patients with heart and lung conditions;
· molecular and cellular mechanisms underlying heart and lung diseases, including genetics, epigenetics, and immunology;
· novel technologies, devices, and digital health solutions for the assessment and management of cardiovascular and pulmonary disorders;
· combined therapies and nursing between heart and lung;
· anatomy and function of heart and lung;
· mechanism and physiology research of heart and lung;
· others.